The Department of Veterans Affairs secured more than $10 billion in pharmaceutical price reductions in Fiscal Year 2026, one of the largest single-year procurement efficiency gains in the department’s history, the VA announced Sept. 11. The savings were achieved through aggressive negotiation with pharmaceutical manufacturers and formulary management, enabling the

The Department of Health and Human Services announced more than $380 million to strengthen America’s behavioral health infrastructure, timed to 988 Day, the national awareness day for the 988 Suicide and Crisis Lifeline, on Sept. 8. The funding supports 988 crisis centers, community mental health services, substance use disorder treatment,

The Food and Drug Administration announced two Class I recalls, the agency’s highest hazard level, affecting broccoli sprouts distributed to multiple states and a nationwide recall of epinephrine injection vials used to treat severe allergic reactions, on Sept. 11. Evergreen Fresh Sprouts LLC is recalling broccoli sprouts due to potential

The Department of Health and Human Services awarded more than $225 million on Sept. 8 to improve nutrition, facilities and services at Head Start early childhood programs nationwide. The investment targets the nutrition component of Head Start at a time when the administration’s food agenda emphasizes whole foods and reduced

The Department of Health and Human Services announced key leadership selections at the Food and Drug Administration on Sept. 8, installing new senior officials tasked with promoting innovation, regulatory reform and the administration’s national health priorities. The leadership changes come as the FDA faces significant pressure to reform its approach

The Department of Health and Human Services awarded more than $380 million to strengthen the nation’s behavioral health system on Sept. 8, the anniversary of the 988 Suicide and Crisis Lifeline known as 988 Day. The funding package, one of the largest single-day behavioral health investments in recent federal history,

The Centers for Medicare and Medicaid Services announced a crackdown on a $3.4 billion Medicare fraud scheme on Sept. 8, targeting companies that billed the program for durable medical equipment supplied to beneficiaries who had already died. The enforcement action, conducted under the White House Anti-Fraud Task Force, is one

The Department of the Treasury announced Sept. 9 that its financial intelligence operations uncovered $17.5 billion in suspected healthcare fraud, one of the largest single-day healthcare fraud announcements in the department’s history. The disclosure, linked to the White House Anti-Fraud Task Force’s enforcement campaign, represents a major escalation in the

B. Braun Medical recalled intravenous saline bags due to iron oxide particulate matter found in the product, while American Regent separately recalled epinephrine multi-dose vials over particulate contamination and sterility concerns on Sept. 3. Both products are widely used in hospitals and clinical settings across the United States, and particulate

HHS announced more than $225 million in grants to improve nutrition quality, update aging facilities, and expand services for approximately 800,000 low-income children enrolled in Head Start programs nationwide on Sept. 8. The funding is part of HHS’s broader commitment to child health and development and aligns with Secretary Robert

HHS Secretary Robert F. Kennedy Jr. announced key leadership appointments at the Food and Drug Administration, signaling continued transformation of the agency under the administration’s health and regulatory reform agenda, on Sept. 8. The selections represent Kennedy’s ongoing effort to restructure the FDA’s leadership and priorities at the agency responsible

HHS Secretary Robert F. Kennedy Jr. announced more than $380 million in grants to strengthen suicide prevention and mental health crisis services nationwide on Sept. 8. The date is designated as 988 Suicide and Crisis Lifeline awareness day. The funding represents one of the largest single-day behavioral health investments in

The Centers for Medicare & Medicaid Services took enforcement action against a durable medical equipment fraud scheme totaling $3.4 billion in false claims submitted on behalf of deceased Medicare beneficiaries on Sept. 8. The scheme is one of the largest single Medicare fraud enforcement actions in recent memory and was

The Food and Drug Administration granted accelerated approval to a new breast cancer treatment on Sept. 4, continuing a major stretch of oncology actions by the agency. The accelerated approval pathway allows the FDA to approve drugs for serious conditions based on a surrogate endpoint reasonably likely to predict clinical

The Food and Drug Administration announced regulatory actions to maintain access to life-saving starter nutrition products for newborns on Sept. 4, addressing supply chain vulnerabilities exposed by the 2022 infant formula crisis. The actions are designed to prevent a repeat of the 2022 shortage that left pharmacy and grocery store